 Brian Herrmann
Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 4 | 2024 | 249 | 1.370 |
Why?
| | Sleep Apnea, Obstructive | 4 | 2024 | 302 | 1.270 |
Why?
| | Hearing Loss, Sensorineural | 3 | 2024 | 73 | 1.080 |
Why?
| | Adenoma, Pleomorphic | 2 | 2023 | 9 | 1.000 |
Why?
| | Haemophilus influenzae | 2 | 2024 | 67 | 0.990 |
Why?
| | Salivary Gland Neoplasms | 2 | 2023 | 39 | 0.970 |
Why?
| | Tympanoplasty | 2 | 2022 | 9 | 0.910 |
Why?
| | Tympanic Membrane Perforation | 2 | 2022 | 18 | 0.910 |
Why?
| | Olfaction Disorders | 2 | 2023 | 70 | 0.900 |
Why?
| | Palatine Tonsil | 2 | 2024 | 54 | 0.900 |
Why?
| | Meningitis, Bacterial | 2 | 2024 | 46 | 0.840 |
Why?
| | Child | 30 | 2026 | 22707 | 0.840 |
Why?
| | Meningitis, Haemophilus | 1 | 2023 | 6 | 0.810 |
Why?
| | Haemophilus Infections | 1 | 2024 | 45 | 0.800 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 2023 | 5 | 0.800 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2023 | 5 | 0.800 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 172 | 0.790 |
Why?
| | Carcinoma, Acinar Cell | 1 | 2023 | 4 | 0.790 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2023 | 14 | 0.790 |
Why?
| | Parotid Neoplasms | 1 | 2023 | 15 | 0.780 |
Why?
| | Meningitis, Pneumococcal | 1 | 2023 | 7 | 0.780 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 101 | 0.770 |
Why?
| | Lymphadenopathy | 1 | 2022 | 8 | 0.750 |
Why?
| | Histiocytosis, Sinus | 1 | 2022 | 7 | 0.750 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.730 |
Why?
| | Tonsillectomy | 2 | 2021 | 105 | 0.720 |
Why?
| | Adenoidectomy | 2 | 2021 | 81 | 0.660 |
Why?
| | Epidermal Cyst | 1 | 2020 | 13 | 0.640 |
Why?
| | Dermoid Cyst | 1 | 2020 | 14 | 0.640 |
Why?
| | Hearing Loss, Conductive | 4 | 2025 | 24 | 0.640 |
Why?
| | Mouth Diseases | 1 | 2020 | 47 | 0.620 |
Why?
| | Liposarcoma, Myxoid | 1 | 2019 | 10 | 0.590 |
Why?
| | Li-Fraumeni Syndrome | 1 | 2019 | 15 | 0.590 |
Why?
| | Facial Neoplasms | 1 | 2019 | 19 | 0.590 |
Why?
| | Septo-Optic Dysplasia | 1 | 2019 | 5 | 0.590 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 350 | 0.580 |
Why?
| | Databases, Factual | 2 | 2026 | 1490 | 0.570 |
Why?
| | Retrospective Studies | 19 | 2026 | 17291 | 0.560 |
Why?
| | Otitis Media | 5 | 2026 | 182 | 0.560 |
Why?
| | Child, Preschool | 16 | 2026 | 11853 | 0.560 |
Why?
| | Perception | 1 | 2021 | 378 | 0.530 |
Why?
| | Infant | 12 | 2026 | 10077 | 0.510 |
Why?
| | Body Weight | 1 | 2021 | 971 | 0.490 |
Why?
| | Mastoidectomy | 2 | 2026 | 5 | 0.470 |
Why?
| | Ear, Middle | 3 | 2024 | 84 | 0.460 |
Why?
| | Paranasal Sinus Diseases | 2 | 2005 | 15 | 0.450 |
Why?
| | Lymphoproliferative Disorders | 2 | 2005 | 57 | 0.440 |
Why?
| | Middle Ear Ventilation | 3 | 2026 | 18 | 0.410 |
Why?
| | Rhinitis | 2 | 2006 | 169 | 0.390 |
Why?
| | Male | 25 | 2026 | 72843 | 0.380 |
Why?
| | Humans | 36 | 2026 | 145475 | 0.370 |
Why?
| | Female | 25 | 2026 | 78845 | 0.370 |
Why?
| | Parents | 1 | 2021 | 1403 | 0.350 |
Why?
| | Lung Transplantation | 2 | 2005 | 332 | 0.350 |
Why?
| | Hearing Loss, Bilateral | 2 | 2023 | 13 | 0.350 |
Why?
| | Head and Neck Neoplasms | 2 | 2005 | 561 | 0.300 |
Why?
| | Adolescent | 13 | 2026 | 22530 | 0.280 |
Why?
| | Epidural Abscess | 2 | 2006 | 7 | 0.270 |
Why?
| | Tomography, X-Ray Computed | 5 | 2024 | 2769 | 0.260 |
Why?
| | Sphenoid Sinusitis | 1 | 2006 | 4 | 0.250 |
Why?
| | Frontal Sinusitis | 1 | 2006 | 3 | 0.240 |
Why?
| | Mastoiditis | 1 | 2026 | 10 | 0.240 |
Why?
| | Blindness | 1 | 2006 | 51 | 0.240 |
Why?
| | Neck | 2 | 2022 | 108 | 0.230 |
Why?
| | Mandibular Fractures | 1 | 2026 | 16 | 0.230 |
Why?
| | Central Nervous System Infections | 1 | 2006 | 35 | 0.230 |
Why?
| | Magnetic Resonance Imaging | 5 | 2020 | 3904 | 0.230 |
Why?
| | Mycoses | 1 | 2006 | 88 | 0.230 |
Why?
| | Ear Canal | 1 | 2025 | 14 | 0.220 |
Why?
| | Craniofacial Dysostosis | 1 | 2005 | 3 | 0.220 |
Why?
| | Ear, Inner | 1 | 2025 | 51 | 0.220 |
Why?
| | Audiometry | 1 | 2025 | 35 | 0.220 |
Why?
| | Ear | 1 | 2025 | 31 | 0.220 |
Why?
| | Ear, External | 1 | 2005 | 21 | 0.220 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2005 | 21 | 0.220 |
Why?
| | Smell | 2 | 2023 | 126 | 0.220 |
Why?
| | Cochlea | 1 | 2025 | 73 | 0.220 |
Why?
| | Noise | 1 | 2025 | 72 | 0.220 |
Why?
| | Lipoma | 1 | 2004 | 17 | 0.220 |
Why?
| | Turbinates | 1 | 2024 | 14 | 0.210 |
Why?
| | Fibroma | 1 | 2004 | 21 | 0.210 |
Why?
| | Empyema, Subdural | 1 | 2004 | 1 | 0.210 |
Why?
| | Congenital Abnormalities | 1 | 2025 | 109 | 0.210 |
Why?
| | Eustachian Tube | 1 | 2024 | 9 | 0.210 |
Why?
| | Endoscopes | 1 | 2024 | 17 | 0.210 |
Why?
| | Connective Tissue | 1 | 2004 | 38 | 0.210 |
Why?
| | Transplants | 1 | 2004 | 38 | 0.200 |
Why?
| | Orbital Diseases | 1 | 2004 | 37 | 0.200 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 90 | 0.200 |
Why?
| | Parotid Gland | 1 | 2023 | 17 | 0.200 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2004 | 71 | 0.200 |
Why?
| | Neuroblastoma | 1 | 2005 | 174 | 0.200 |
Why?
| | Submandibular Gland | 1 | 2023 | 20 | 0.190 |
Why?
| | Cleft Lip | 1 | 2024 | 73 | 0.190 |
Why?
| | Nose Neoplasms | 1 | 2003 | 22 | 0.190 |
Why?
| | Nasal Mucosa | 1 | 2004 | 112 | 0.190 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2003 | 29 | 0.190 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2023 | 36 | 0.190 |
Why?
| | Vaccines, Conjugate | 1 | 2023 | 59 | 0.190 |
Why?
| | Retropharyngeal Abscess | 1 | 2002 | 7 | 0.190 |
Why?
| | Hyperplasia | 1 | 2023 | 177 | 0.190 |
Why?
| | Cleft Palate | 1 | 2024 | 91 | 0.190 |
Why?
| | Steroids | 1 | 2023 | 160 | 0.190 |
Why?
| | Nasal Cavity | 1 | 2003 | 61 | 0.190 |
Why?
| | Paclitaxel | 1 | 2004 | 257 | 0.190 |
Why?
| | Rhabdomyosarcoma | 1 | 2003 | 65 | 0.180 |
Why?
| | Down-Regulation | 1 | 2024 | 618 | 0.180 |
Why?
| | Pneumococcal Vaccines | 1 | 2023 | 129 | 0.180 |
Why?
| | Hearing | 1 | 2023 | 133 | 0.170 |
Why?
| | Sinusitis | 1 | 2004 | 227 | 0.170 |
Why?
| | Streptococcus pneumoniae | 1 | 2023 | 184 | 0.170 |
Why?
| | Ranula | 1 | 2020 | 3 | 0.160 |
Why?
| | Mouth Floor | 1 | 2020 | 7 | 0.160 |
Why?
| | Sleep Apnea Syndromes | 1 | 2021 | 98 | 0.150 |
Why?
| | Stents | 1 | 2004 | 564 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 1 | 2022 | 484 | 0.150 |
Why?
| | Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2019 | 4 | 0.150 |
Why?
| | Hearing Loss, Unilateral | 1 | 2019 | 5 | 0.150 |
Why?
| | Collagen | 1 | 2022 | 457 | 0.150 |
Why?
| | Acoustic Impedance Tests | 1 | 2019 | 13 | 0.150 |
Why?
| | Swine | 1 | 2022 | 825 | 0.150 |
Why?
| | Heart Transplantation | 1 | 2005 | 680 | 0.140 |
Why?
| | RNA, Viral | 1 | 2022 | 692 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2023 | 3623 | 0.140 |
Why?
| | Perioperative Care | 1 | 2021 | 231 | 0.140 |
Why?
| | Acute Disease | 3 | 2026 | 1036 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2002 | 339 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 525 | 0.120 |
Why?
| | Ultrasonography | 1 | 2020 | 785 | 0.120 |
Why?
| | Prospective Studies | 3 | 2023 | 8057 | 0.120 |
Why?
| | Overweight | 1 | 2021 | 614 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 730 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2021 | 638 | 0.100 |
Why?
| | Drainage | 2 | 2026 | 185 | 0.100 |
Why?
| | Treatment Outcome | 3 | 2022 | 11772 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4295 | 0.100 |
Why?
| | Chronic Disease | 1 | 2019 | 1808 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2930 | 0.090 |
Why?
| | Body Mass Index | 1 | 2021 | 2445 | 0.090 |
Why?
| | Adult | 3 | 2024 | 40777 | 0.090 |
Why?
| | Endoscopy | 2 | 2024 | 317 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5905 | 0.080 |
Why?
| | Pilot Projects | 2 | 2004 | 1891 | 0.070 |
Why?
| | Obesity | 1 | 2021 | 3116 | 0.060 |
Why?
| | Prevalence | 2 | 2024 | 2865 | 0.060 |
Why?
| | Sphenoid Sinus | 1 | 2006 | 7 | 0.060 |
Why?
| | Prognosis | 2 | 2005 | 4316 | 0.060 |
Why?
| | Adenoids | 1 | 2005 | 12 | 0.060 |
Why?
| | Congenital Microtia | 1 | 2025 | 8 | 0.060 |
Why?
| | Mastoid | 1 | 2005 | 12 | 0.060 |
Why?
| | Cholesteatoma | 1 | 2005 | 10 | 0.060 |
Why?
| | Hypertrophy | 1 | 2005 | 128 | 0.060 |
Why?
| | Audiometry, Pure-Tone | 1 | 2005 | 33 | 0.060 |
Why?
| | Limb Deformities, Congenital | 1 | 2005 | 22 | 0.050 |
Why?
| | Headache | 1 | 2006 | 151 | 0.050 |
Why?
| | Nasal Polyps | 1 | 2005 | 59 | 0.050 |
Why?
| | Nasal Obstruction | 1 | 2005 | 26 | 0.050 |
Why?
| | Pressure | 1 | 2025 | 226 | 0.050 |
Why?
| | Multiple Trauma | 1 | 2026 | 121 | 0.050 |
Why?
| | Cadaver | 1 | 2025 | 311 | 0.050 |
Why?
| | Nasal Septum | 1 | 2024 | 30 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2025 | 249 | 0.050 |
Why?
| | Sheep, Domestic | 1 | 2004 | 34 | 0.050 |
Why?
| | Fascia | 1 | 2004 | 19 | 0.050 |
Why?
| | Syndrome | 1 | 2005 | 381 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 54 | 0.050 |
Why?
| | Abscess | 1 | 2004 | 77 | 0.050 |
Why?
| | Coated Materials, Biocompatible | 1 | 2004 | 65 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2004 | 185 | 0.050 |
Why?
| | Hypersensitivity | 1 | 2006 | 254 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2005 | 6447 | 0.050 |
Why?
| | Random Allocation | 1 | 2004 | 365 | 0.050 |
Why?
| | Odorants | 1 | 2023 | 114 | 0.050 |
Why?
| | Animals | 2 | 2022 | 38030 | 0.050 |
Why?
| | Accidental Falls | 1 | 2026 | 226 | 0.050 |
Why?
| | Lymph Nodes | 1 | 2005 | 503 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2023 | 507 | 0.040 |
Why?
| | Thinness | 1 | 2021 | 100 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2004 | 1508 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1716 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1997 | 0.040 |
Why?
| | Athletic Injuries | 1 | 2026 | 571 | 0.040 |
Why?
| | Weight Gain | 1 | 2021 | 561 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2864 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2005 | 5423 | 0.030 |
Why?
| | Hospitalization | 1 | 2026 | 2460 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2026 | 1923 | 0.030 |
Why?
| | Cystic Fibrosis | 1 | 2005 | 1161 | 0.030 |
Why?
| | Postoperative Complications | 1 | 2026 | 2970 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2004 | 4560 | 0.020 |
Why?
| | Risk Factors | 1 | 2004 | 10885 | 0.020 |
Why?
| | United States | 1 | 2026 | 16098 | 0.020 |
Why?
|
|
Herrmann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|